Verona Pharma plc Cash Flow-to-Debt Ratio
Verona Pharma plc cash flow-to-debt ratio. Verona Pharma plc (I9SA) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2025, meaning its operating cash flow of €30.56 Million could theoretically repay 0% of its total liabilities (€294.60 Million) in one year. Check Verona Pharma plc (I9SA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Verona Pharma plc (2016–2024)
Cash flow-to-debt ratio of Verona Pharma plc from 2016 to 2024. Historical debt coverage capacity for Verona Pharma plc across 9 annual periods. Check I9SA operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Verona Pharma plc Cash Flow-to-Debt Ratio by Year (2016–2024)
Verona Pharma plc cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for Verona Pharma plc. For the full cash flow conversion analysis, see cash efficiency ratio of Verona Pharma plc.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.45x | €-122.20 Million | €269.68 Million | ▲ +46.9% |
| 2023 | -0.85x | €-50.22 Million | €58.84 Million | ▲ +58.6% |
| 2022 | -2.06x | €-59.86 Million | €29.00 Million | ▼ -139.5% |
| 2021 | -0.86x | €-33.25 Million | €38.58 Million | ▲ +63.0% |
| 2020 | -2.33x | €-45.08 Million | €19.35 Million | ▲ +19.7% |
| 2019 | -2.90x | €-42.87 Million | €14.78 Million | ▼ -130.2% |
| 2018 | -1.26x | €-18.11 Million | €14.37 Million | ▲ +20.8% |
| 2017 | -1.59x | €-20.70 Million | €13.00 Million | ▼ -310.4% |
| 2016 | -0.39x | €-5.59 Million | €14.40 Million | — |